DocSym
β
Searchsearch
Search
(N85.1) Endometrial adenomatous hyperplasia
More details coming soon
3 565 710 in individuals diagnosis endometrial adenomatous hyperplasia confirmed
1 594 deaths with diagnosis endometrial adenomatous hyperplasia
Diagnosis endometrial adenomatous hyperplasia is diagnosed Prevalent in Women Only
0
Men receive the diagnosis endometrial adenomatous hyperplasia
0 (No mortality)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
3 565 710
Women receive the diagnosis endometrial adenomatous hyperplasia
1 594 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease endometrial adenomatous hyperplasia - Men aged 0 and Women aged 50-54
No Cases of the Disease Endometrial adenomatous hyperplasia identified in Men
Less common in men the disease occurs at Age 0-95+Less common in women the disease occurs at Age 0-5
In Women diagnosis is most often set at age 5-95+
Disease Features endometrial adenomatous hyperplasia
Absence or low individual and public risk
Endometrial adenomatous hyperplasia - what does this mean
Endometrial adenomatous hyperplasia is a condition in which the endometrium (inner lining of the uterus) becomes thickened due to an increase in the number of endometrial glands and stroma. this condition is usually caused by an imbalance of hormones, such as an excess of estrogen or a deficiency of progesterone. it is most commonly seen in women in their late reproductive years and can lead to abnormal bleeding and an increased risk of endometrial cancer.
What happens during the disease - endometrial adenomatous hyperplasia
Endometrial adenomatous hyperplasia is caused by an increase in the hormones estrogen and progesterone, which stimulate the endometrium to grow. the endometrial cells become abnormal and divide more rapidly than normal, leading to an accumulation of cells and a thickening of the endometrium. this results in an overgrowth of the endometrium, leading to the formation of adenomatous tissue, which can cause problems with fertility and menstrual irregularities.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Pelvic Exam
- Pap Smear
- Ultrasound
- Endometrial Biopsy
- Hysteroscopy
- Blood Tests
Treatment and Medical Assistance
Main Goal: To reduce the risk of endometrial cancer
- Perform a biopsy to confirm the diagnosis
- Prescribe progestin therapy
- Administer GnRH agonists
- Prescribe anti-inflammatory medications
- Administer Tamoxifen
- Perform a hysterectomy
- Perform a laparoscopy
- Prescribe dietary changes
- Encourage regular exercise
- Advise patient to quit smoking
3 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Endometrial adenomatous hyperplasia - Prevention
Endometrial adenomatous hyperplasia can be prevented through lifestyle changes such as maintaining a healthy weight, exercising regularly, and avoiding smoking and excessive alcohol consumption. additionally, taking hormone therapy medications such as progestin can help reduce the risk of developing endometrial adenomatous hyperplasia.